Rapid Micro Biosystems, Inc. Class A Common Stock (RPID) is a publicly traded Healthcare sector company. As of July 24, 2026, RPID trades at $1.99 with a market cap of $102.63M and a P/E ratio of -1.79. RPID moved -3.16% today. Year to date, RPID is -31.38%; over the trailing twelve months it is -50.62%. Its 52-week range spans $0.87 to $4.94. Analyst consensus is strong buy with an average price target of $6.67. Rallies surfaces RPID's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for RPID shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $1.99 |
| Market Cap | $102.63M |
| P/E Ratio | -1.79 |
| EPS | $-1.11 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.94 |
| 52-Week Low | $0.87 |
| Volume | 411.86K |
| Avg Volume | 0 |
| Revenue (TTM) | $34.38M |
| Net Income | $-50.13M |
| Gross Margin | 0.00% |
4 analysts cover RPID: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $6.67.